Recap: Amphastar Pharma Q3 Earnings

Amphastar Pharma AMPH reported its Q3 earnings results on Wednesday, November 8, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Amphastar Pharma beat estimated earnings by 66.67%, reporting an EPS of $1.15 versus an estimate of $0.69.

Revenue was up $60.43 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.09 which was followed by a 4.29% drop in the share price the next day.

Here's a look at Amphastar Pharma's past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate 0.56 0.48 0.41 0.39
EPS Actual 0.65 0.62 0.73 0.38
Revenue Estimate 137.37M 136.33M 126.98M 126.37M
Revenue Actual 145.71M 140.02M 135.02M 120.13M

To track all earnings releases for Amphastar Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!